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Purpose: To elucidate the molecular genetic defect of X-linked congenital nystagmus in a Chinese family.
Methods: Genomic DNA was prepared from peripheral blood. We used allele-sharing analysis to identify the possible
locus harboring the disease-causing gene. We screened for mutations in the G protein-coupled receptor 143 gene
(GPR143) by direct sequencing of the polymerase chain reaction (PCR)-amplified exons.
Results: In analyzing the candidate gene, GPR143, in the linked region, a 19 base pair (bp) duplication mutation in exon
1 was detected after direct DNA sequence analysis, which cosegregated in all patients of this family and was present in
obligate female carriers.
Conclusions: The identified 19 bp duplication in GPR143 induces a frame-shift and a premature stop codon, resulting in
a truncated protein of 105 residues. These results suggest that this novel mutation is associated with the congenital
nystagmus observed in this Chinese family and further support that GPR143 mutations are the underlying pathogenesis
of the molecular mechanism for congenital nystagmus.
Congenital  nystagmus  (CN)  is  an  ocular  hereditary
disorder characterized by binocular spontaneous oscillations
with onset typically at birth or within the first few months of
life  [1].  Patients’  oscillations  can  be  horizontal,  vertical,
torsional, or any combination of these. Reduced vision and
poor depth perception are the major symptoms. Congenital
nystagmus  (frequency  of  1/20,000  live  births  [2])
predominantly occurs secondary to the genetic ocular diseases
such  as  albinism,  achromatopsia,  and  Leber  congenital
amaurosis. So far, X-linked dominant and X-linked recessive
(OMIM  310700),  autosomal  dominant  (OMIM  164100,
OMIM 608345, OMIM 193003), and autosomal recessive
(OMIM 257400) modes of inheritance have been reported, but
X-linked inheritance with incomplete penetrance and variable
expressivity is probably the most common. Three different
genetic  loci  for  X-linked  CN  have  been  mapped  to
chromosomes Xp11.3–11.4 [3], Xp22 [4], and Xq26-Xq27
[5].
The four-point-one (4.1), ezrin, radixin, moesin (FERM)
domain  -containing  7  gene  (FRMD7;  OMIM  300628)  at
Xq26–27 [6] and the G protein-coupled receptor 143 gene
(GPR143, OMIM 300500) at Xp22 [4] have been identified
as disease-causing genes for X-linked CN, but the molecular
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pathogenic mechanism is largely unknown. To date, multiple
mutations of FRMD7 have been reported. The latter gene,
GPR143, causes ocular albinism type 1 (OA1), which is an X-
linked albinism that mainly effects pigment production in the
eye in which affected males show all the ocular signs of
albinism  including  severely  impaired  visual  activity,
nystagmus,  photophobia,  iris  transillumination,
hypopigmentation  of  retinal  pigmented  epithelium,  foveal
hypoplasia,  and  misrouting  of  optic  tracts  [7].  However,
GPR143  mutations  have  been  identified  in  two  Chinese
families with X-linked CN without any classical phenotype of
OA1 [4,8].
In this study, we present a four-generation Chinese family
with  X-linked  CN.  All  affected  individuals  exhibited
nystagmus  but  without  any  typical  signs  of  OA1.  Upon
genetic analysis, we characterized the underlying molecular
defect as a novel 19 base pair (bp) duplication in exon 1 of
GPR143, causing a frame-shift in all affected males. Our
results indicate that this novel GPR143 mutation might be
associated with the congenital nystagmus observed in this
Chinese family.
METHODS
Family data: The study had the approval of the Institute of
Basic Medical Sciences ethics committee (Beijing, China) and
conformed to the tenets of the Declaration of Helsinki. A four-
generation Chinese family with X-linked CN was identified
in Peking Union Medical College Hospital (Beijing, China)
in 1999 [9]. Sample collection was just available from a small
part of the whole family (Figure 1). Blood samples were taken
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810after  informed  written  consent  from  14  family  members
including three affected individuals.
Allele-sharing  analysis:  Allele-sharing  analysis  was
performed  on  three  affected  male  individuals  with  two
microsatellite markers (DXS1047 and DXS8071) linked with
FRMD7  and  three  microsatellite  markers  (DXS7108,
AF003664, and DXS9850) linked with GPR143. The primer
sequences  were  taken  from  the  GDB  Human  Genome
database.
Mutation detection: Genomic DNA was extracted from the
peripheral lymphocytes of available subjects. All nine exons
of GPR143 (NM_000273) and part of the flanking intronic
regions were amplified by polymerase chain reaction (PCR)
from  genomic  DNA,  and  each  fragment  was  sequenced
directly. PCR primers were designed by the PRIMER3 online
software, and the sequences were presented in Table 1.
RESULTS
Clinical phenotype: In this family, the disease was transmitted
from female carrier to affected son and was an apparent X-
linked  recessive  trait  (Figure  1),  although  all  sons  of  the
carriers  were  affected  unfortunately.  Moreover,  female
carriers such as III:3, III:5, and III:7 have only one child. If
we take a wide view of the intact family pedigree and each of
the female carriers could have more offspring, we are likely
to expect half of the male offspring of carrier females to be
unaffected  by  the  disease.  All  patients  had  binocular
spontaneous  horizontal  oscillations  with  an  intermediate
frequency (<120 counts per minute) without head nodding.
They all had reduced vision, amblyopia, and mild compound
hypermetropic  astigmatism.  However,  choroidal  vessels
could be seen in fundus oculi of two patients with external
strabismus  (15°−20°)  without  optic  fundi  pathological
changes or optic nerve lesions.
Allele-sharing analysis: Allele-sharing analysis of DXS1047
and DXS8071 showed that three patients did not share the
same haplotype, which excluded the possibility of mutation in
FRMD7.  However,  results  of  DXS7108,  AF003664,  and
DXS9850 demonstrated that all three affected males obtained
the same haplotype and further indicated the linkage of the
disease in the family with the mutation in GPR143.
Mutation of GPR143: Upon complete analysis of the coding
and the adjacent intronic regions of GPR143, a previously
unidentified 19 bp duplication (c.291_309) mutation in exon
1  was  identified  in  all  affected  males  (Figure  2).  This
duplication was not detected in normal members of the family
or in 100 normal male individuals. It was predicted to result
in a frame-shift and a premature stop codon emerged in exon
2, resulting in a truncated protein of only 105 amino acids.
Carrier identification: A new pair of primers was designed to
amplify the mutational region in exon 1. Mutation carriers
would obtain two different allele fragments, a 299 bp PCR
fragment, which indicated the mutant allele containing the 19
bp duplication, and a 280 bp fragment, which represented the
wild-type  allele.  We  could  then  determine  that  all
heterozygous individuals (II:1, III:3, III:5, III:7, III:13, and
III:14) were mutation carriers (Figure 3).
TABLE 1. PRIMERS AND PCR CONDITIONS USED TO AMPLIFY GENOMIC SEGMENTS OF GPR143.




       (bp)
Exon 1-F AACCTTCCCAACCTTTCTGC 69 698
1-R CCTCTCGTCCTCACTCCATC
Exon 2-F CAGTGAGCAGGGTTTTTACCA 66 537
2-R AACAGACTCCCAGGGTTTGC
Exon 3-F GTCTACCCTGCCGTCTCAAG 66 334
3-R TGAGCTGCTGTGGATGTTTC
Exon 4-F CTCAGCAGCACGAGGAAACT 67 465
4-R ACAAACGAGAAAGGCAGAGC
Exon 5-F CTTAGGGGTCCTCCCATTTC 65 575
5-R TGGCACTGAGCTAACAAACG
Exon 6-F ATCCCCATGGTTGCATAAGA 64 738
6-R CACATGGTTGGGACATTTCA
Exon 7-F GCACCTGGCCCTCTTAGTTT 67 436
7-R GAGGCCAAGACAGAGGATTG
Exon 8-F TTCAGGCACCCTTGAAGGTA 66 539
8-R CCGGGACAAAGAATCCTCTA
Exon 9-F GGCTTGTGTCATCCGTTGTA 61 488
9-R CCCTTCGGGAAGAAGCTCTA
The primers were selected inside the flanking introns to amplify the fragments containing coding sequence (exons) and the
flanking intronic regions. Primer sequences, size of PCR products, and the annealing temperature for amplification were
indicated.
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In this study, we report a family with typical clinical signs of
X-linked  congenital  nystagmus.  The  sequence  analysis  of
GPR143 identified a novel duplication mutation in exon 1. All
affected males were hemizygous for the mutation whereas
female carriers were heterozygous for the duplication.
Nystagmus is common in all types of albinism. Diagnosis
of the underlying disease often requires extensive clinical,
electrophysiological,  psychophysical,  and  eventually
molecular  genetic  examinations,  especially  when  clinical
findings  are  unrevealing.  A  few  individuals  initially
misdiagnosed with congenital nystagmus have been shown to
be affected by ocular albinism type 1 by screening GPR143
[10,11]. However, in our study, none of the patients with the
GPR143  mutation  had  the  classical  phenotype  of  ocular
albinism.
GPR143  was  cloned  from  the  OA1  critical  region  in
Xp22.3–22.2 in 1995 [7]. To date, more than 90 different
GPR143 mutations have since been described. However, there
were only nine different GPR143 mutations identified in the
Chinese  population,  two  of  which  were  described  in  two
families with X-linked congenital nystagmus [4,8]. Our case
is the third one associated with nystagmus only. Moreover,
this c.291_309dup mutation is only the second duplication
mutation identified until now. GPR143 encodes a protein of
Figure 1. Pedigree of the Chinese family with X-linked congenital nystagmus. Black squares are for affected males, small solid circle within
open circles for obligate carrier females, and open symbols for unaffected individuals.
Figure  2.  Duplication  in  GPR143
identified  in  subject  family  with
congenital nystagmus. A: The sequence
for a normal individual shows the wild-
type  allele.  B:  The  sequence  for  the
patient  (IV:3)  shows  the  19-bp  (c.
291_309) duplication identified in exon
1. We can see that the end part of the
duplicated base pairs is the same with
the  one  just  ahead  of  the  duplication
(shown in the rectangle).
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812404 amino acids containing seven putative transmembrane
domains and one potential N-glycosylation site at codon 106
[12]. Defective glycosylation will result in incorrect protein
localization  [12].  This  c.291_309dup  mutation  leads  to  a
frame-shift and introduces a premature termination codon in
exon 2 of GPR143. It will result in a predicted protein of 105
amino  acids,  which  just  encodes  two  NH2-terminal
transmembrane α-helices and loses the potential glycosylation
site at codon 106. Therefore, the mutant transcript is likely to
be degraded by the nonsense-mediated mRNA decay (NMD)
mechanism [13]. It was not verified in our research since we
were unable to obtain related RNA of disease tissues.
Two Chinese families with X-linked CN have already
been reported to have GPR143 mutations. One family had a
missense mutation [4], which resulted in the substitution of a
serine residue with a phenylalanine residue in exon 2. The
other had a 37 bp deletion, which caused a frame-shift and
resulted in a truncated protein of 93 residues [8]. Moreover,
another GPR143 14 bp deletion mutation in exon 6 was also
identified in white males in a family with X-linked congenital
nystagmus  [14].  As  compared  to  these  findings,  the
duplication found in our study provides another persuasive
evidence of an association between the GPR143 mutation and
CN  in  the  Chinese  population.  Our  results  expand  the
spectrum  of  clinical  phenotypes  associated  with  GPR143
mutations.  Different  degrees  of  phenotypes  caused  by
GPR143 mutations have been previously reported in other
populations  [15].  The  heterogeneity  of  the  clinical
manifestations suggests the existence of modifying genetic,
epigenetic, or environmental factors [16]. Perhaps CN is the
only phenotype of OA1 in some ethnic populations, and it
supports the hypothesis that CN may be a form of ocular
albinism [17].
Many  GPR143  gross  deletion  mutations  have  been
reported, which were believed to be the result of a homologous
but unequal crossing-over involving two repetitive sequences
such as the Alu family [18-20]. Our finding is only the second
duplication mutation so far reported in GPR143. We can see
the end part of the duplicated base pairs (GCTGCCTG) is the
same with the one just ahead the duplication (Figure 2). The
first identified duplication mutation, c.163_170dup, was also
located in exon 1 of high GC content [18]. The duplicated
DNA sequence (GCGGGCCC) is extremely similar to the
upstream  DNA  sequence  (GCCGGCCC).  Therefore,  high
similarity between the DNA sequences may be the cause of
these mutations, and high GC content is the foundation of the
similarity. These mutations might be explained by replication
error.  However,  the  possibility  of  unequal  crossing-over
cannot be excluded before the real mechanism is disclosed.
Our results provide additional evidence that mutations in
GPR143 are another cause of congenital nystagmus in the
Chinese population. Our findings also expand its mutation
spectrum and can be useful for gene diagnosis and genetic
counseling in Chinese CN patients. We believe that further
biochemical studies of the mutations in GPR143 will yield
insight  into  its  molecular  mechanism  underlying  the
pathogenesis of congenital nystagmus.
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